Veronica Höiom

Publications
Grants
Public outreach and news

Articles

Article: JCO PRECISION ONCOLOGY. 2022;6:e2200145
Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer
Astiazaran-Symonds E; Graham C; Kim J; Tucker MA; Ingvar C; Helgadottir H; Pastorino L; van Doorn R; Sampson JN; Zhu B; Bruno W; Queirolo P; Fornarini G; Sciallero S; Carter B; Hicks B; Hutchinson A; Jones K; Stewart DR; Chanock SJ; Freedman ND; Landi MT; Hoiom V; Puig S; Gruis N; Yang XR; Ghiorzo P; Goldstein AM
Article: CANCERS. 2022;14(15):3587
Proliferation and Immune Response Gene Signatures Associated with Clinical Outcome to Immunotherapy and Targeted Therapy in Metastatic Cutaneous Malignant Melanoma
Svedman FC; Das I; Tuominen R; Ramqvist ED; Hoiom V; Brage SE
Article: BIOMEDICINES. 2022;10(5):1004
Whole-Exome Sequencing of Germline Variants in Non-BRCA Families with Hereditary Breast Cancer
Liu Y; Helgadottir HT; Kharaziha P; Choi J; Lopez-Giraldez F; Mane SM; Hoiom V; Juhlin CC; Larsson C; Bajalica-Lagercrantz S
Article: CANCERS. 2022;14(3):702
Plasma Thymidine Kinase Activity as a Novel Biomarker in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibitors
Costa Svedman F; Jalsenius M; Hoeiom V; Grozman V; Bergqvist M; Soederdahl F; Eriksson H; Rotstein S; Ny L; Ascierto PA; Brage SE; Helgadottir H
Article: ACTA ONCOLOGICA. 2022;61(1):14-21
A biomarker panel predicts recurrence-free survival in ulcerated primary cutaneous melanoma
Falkenius J; Keskitalo J; Kanter L; Johansson H; Hoiom V; Hansson J; Brage SE
Article: GENETICS IN MEDICINE. 2022;24(1):157-169
Novel loss-of-function variant in DENND5A impedes melanosomal cargo transport and predisposes to familial cutaneous melanoma
Yang M; Johnsson P; Brautigam L; Yang XR; Thrane K; Gao J; Tobin NP; Zhou Y; Yu R; Nagy N; Engstrom PG; Tuominen R; Eriksson H; Lundeberg J; Tucker MA; Goldstein AM; Egyhazi-Brage S; Zhao J; Cao Y; Hoiom V
Article: GENETICS IN MEDICINE. 2021;23(11):2087-2095
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia
Dalmasso B; Pastorino L; Nathan V; Shah NN; Palmer JM; Howlie M; Johansson PA; Freedman ND; Carter BD; Beane-Freeman L; Hicks B; Molven A; Helgadottir H; Sankar A; Tsao H; Stratigos AJ; Helsing P; Van Doorn R; Gruis NA; Visser M; Wadt KAW; Mann G; Holland EA; Nagore E; Potrony M; Puig S; Menin C; Peris K; Fargnoli MC; Calista D; Soufir N; Harland M; Bishop T; Kanetsky PA; Elder DE; Andreotti V; Vanni I; Bruno W; Hoiom V; Tucker MA; Yang XR; Andresen PA; Adams DJ; Landi MT; Hayward NK; Goldstein AM; Ghiorzo P
Article: ACTA ONCOLOGICA. 2021;60(7):888-896
CDKN2A genetic testing in melanoma-prone families in Sweden in the years 2015-2020: implications for novel national recommendations
Pissa M; Helkkula T; Appelqvist F; Silander G; Borg A; Pettersson J; Lapins J; Nielsen K; Hoiom V; Helgadottir H
Article: CANCER RESEARCH. 2021;81(9):2545-2555
Inflammation and Apolipoproteins Are Potential Biomarkers for Stratification of Cutaneous Melanoma Patients for Immunotherapy and Targeted Therapy
Karlsson MJ; Svedman FC; Tebani A; Kotol D; Hoiom V; Fagerberg L; Edfors F; Uhlen M; Brage SE; Maddalo G
Article: BMC PUBLIC HEALTH. 2021;21(1):692
Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families
Lacson JCA; Zamani SA; Froes Jr LAR; Mitra N; Qian L; Doyle SH; Azizi E; Balestrini C; Bishop DT; Bruno W; Carlos-Ortega B; Cuellar F; Cust AE; Elder DE; Gerdes A-M; Ghiorzo P; Grazziotin TC; Gruis NA; Hansson J; Hocevar M; Hoiom V; Holland EA; Ingvar C; Landman G; Larre-Borges A; Mann GJ; Molgo M; Moredo LF; Olsson H; Out-Luiting JJ; Peric B; Pjanova D; Puig S; Salas-Alanis J; Schmid H; Wadt KAW; Newton-Bishop JA; Kanetsky PA
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2021;113(3):318-328
Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study
Helgadottir H; Isaksson K; Fritz I; Ingvar C; Lapins J; Hoiom V; Newton-Bishop J; Olsson H
Article: MELANOMA RESEARCH. 2020;30(5):500-510
MC1R variants and cutaneous melanoma risk according to histological type, body site, and Breslow thickness: a pooled analysis from the M-SKIP project
Caini S; Gandini S; Botta F; Tagliabue E; Raimondi S; Nagore E; Zanna I; Maisonneuve P; Newton-Bishop J; Polsky D; Lazovich D; Kumar R; Kanetsky PA; Hoiom V; Ghiorzo P; Landi MT; Ribas G; Menin C; Stratigos AJ; Palmieri G; Guida G; Garcia-Borron JC; Nan H; Little J; Sera F; Puig S; Fargnoli MC
Article: MELANOMA RESEARCH. 2020;30(5):443-454
Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib
Vidarsdottir L; Fernandes RV; Zachariadis V; Das I; Edsbacker E; Sigvaldadottir I; Azimi A; Hoiom V; Hansson J; Grander D; Egyhazi Brage S; Pokrovskaja Tamm K
Article: CELL DEATH AND DIFFERENTIATION. 2020;27(7):2081-2098
AXL and CAV-1 play a role for MTH1 inhibitor TH1579 sensitivity in cutaneous malignant melanoma
Das I; Gad H; Braeutigam L; Pudelko L; Tuominen R; Hoiom V; Almlof I; Rajagopal V; Hansson J; Helleday T; Brage SE; Berglund UW
Article: NATURE GENETICS. 2020;52(5):494-504
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility
Landi MT; Bishop DT; MacGregor S; Machiela MJ; Stratigos AJ; Ghiorzo P; Brossard M; Calista D; Choi J; Fargnoli MC; Zhang T; Rodolfo M; Trower AJ; Menin C; Martinez J; Hadjisavvas A; Song L; Stefanaki I; Scolyer R; Yang R; Goldstein AM; Potrony M; Kypreou KP; Pastorino L; Queirolo P; Pellegrini C; Cattaneo L; Zawistowski M; Gimenez-Xavier P; Rodriguez A; Elefanti L; Manoukian S; Rivoltini L; Smith BH; Loizidou MA; Del Regno L; Massi D; Mandala M; Khosrotehrani K; Akslen LA; Amos CI; Andresen PA; Avril M-F; Azizi E; Soyer HP; Bataille V; Dalmasso B; Bowdler LM; Burdon KP; Chen WV; Codd V; Craig JE; Debniak T; Falchi M; Fang S; Friedman E; Simi S; Galan P; Garcia-Casado Z; Gillanders EM; Gordon S; Green A; Gruis NA; Hansson J; Harland M; Harris J; Helsing P; Henders A; Hocevar M; Hoiom V; Hunter D; Ingvar C; Kumar R; Lang J; Lathrop GM; Lee JE; Li X; Lubinski J; Mackie RM; Malt M; Malvehy J; McAloney K; Mohamdi H; Molven A; Moses EK; Neale RE; Novakovic S; Nyholt DR; Olsson H; Orr N; Fritsche LG; Anton Puig-Butille J; Qureshi AA; Radford-Smith GL; Randerson-Moor J; Requena C; Rowe C; Samani NJ; Sanna M; Schadendorf D; Schulze H-J; Simms LA; Smithers M; Song F; Swerdlow AJ; van der Stoep N; Kukutsch NA; Visconti A; Wallace L; Ward SV; Wheeler L; Sturm RA; Hutchinson A; Jones K; Malasky M; Vogt A; Zhou W; Pooley KA; Elder DE; Han J; Hicks B; Hayward NK; Kanetsky PA; Brummett C; Montgomery GW; Olsen CM; Hayward C; Dunning AM; Martin NG; Evangelou E; Mann GJ; Long G; Pharoah PDP; Easton DF; Barrett JH; Cust AE; Abecasis G; Duffy DL; Whiteman DC; Gogas H; De Nicolo A; Tucker MA; Newton-Bishop JA; Peris K; Chanock SJ; Demenais F; Brown KM; Puig S; Nagore E; Shi J; Iles MM; Law MH
Article: JOURNAL OF MEDICAL GENETICS. 2020;57(5):316-321
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
Helgadottir H; Ghiorzo P; van Doorn R; Puig S; Levin M; Kefford R; Lauss M; Queirolo P; Pastorino L; Kapiteijn E; Potrony M; Carrera C; Olsson H; Hoiom V; Jonsson G
Article: ACTA NEUROPATHOLOGICA. 2020;139(2):347-364
Overlapping genetic architecture between Parkinson disease and melanoma
Dube U; Ibanez L; Budde JP; Benitez BA; Davis AA; Harari O; Iles MM; Law MH; Brown KM; Agee M; Alipanahi B; Auton A; Bell RK; Bryc K; Elson SL; Fontanillas P; Furlotte NA; Hinds DA; Huber KE; Kleinman A; Litterman NK; McCreight JC; McIntyre MH; Mountain JL; Noblin ES; Northover CAM; Pitts SJ; Sathirapongsasuti JF; Sazonova OV; Shelton JF; Shringarpure S; Tian C; Tung JY; Vacic V; Wilson CH; Law MH; Law MH; Bishop DT; Lee JE; Brossard M; Martin NG; Moses EK; Song F; Barrett JH; Kumar R; Easton DF; Pharoah PD; Swerdlow AJ; Kypreou KP; Taylor JC; Harland M; Randerson-Moor J; Akslen LA; Andresen PA; Avril MF; Azizi E; Scarra GB; Brown KM; Debniak T; Duffy DL; Elder DE; Fang S; Friedman E; Galan P; Ghiorzo P; Gillanders EM; Goldstein AM; Gruis NA; Hansson J; Helsing P; Hocevar M; Hoiom V; Ingvar C; Kanetsky PA; Chen WV; Landi MT; Lang J; Lathrop GM; Lubinski J; Mackie RM; Mann GJ; Molven A; Montgomery GW; Novakovic S; Olsson H; Puig S; Puig-Butille JA; Wu W; Qureshi AA; Radford-Smith GL; Van der Stoep N; Van Doorn R; Whiteman DC; Craig JE; Schadendorf E; Simms LA; Burdon KP; Nyholt DR; Pooley KA; Orr N; Stratigos AJ; Cust AE; Ward SV; Hayward NK; Han J; Schulze HJ; Dunning AM; Bishop JA; Demenais F; Amos CI; MacGregor S; Iles MM; Cruchaga C
Article: MELANOMA RESEARCH. 2019;29(5):483-490
Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma
Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch A-M; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Hoiom V; Wadt K; Jonsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL
Article: CELL DEATH & DISEASE. 2019;10(9):663
Combining ERBB family and MET inhibitors is an effective therapeutic strategy in cutaneous malignant melanoma independent of BRAF/NRAS mutation status
Das I; Wilhelm M; Hoiom V; Marquez RF; Svedman FC; Hansson J; Tuominen R; Brage SE
Article: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2019;81(2):386-394
Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT
Taylor NJ; Mitra N; Qian L; Avril M-F; Bishop DT; Bressac-de Paillerets B; Bruno W; Calista D; Cuellar F; Cust AE; Demenais F; Elder DE; Gerdes A-M; Ghiorzo P; Goldstein AM; Grazziotin TC; Gruis NA; Hansson J; Harland M; Hayward NK; Hocevar M; Hoiom V; Holland EA; Ingvar C; Landi MT; Landman G; Larre-Borges A; Mann GJ; Nagore E; Olsson H; Palmer JM; Peric B; Pjanova D; Pritchard AL; Puig S; Schmid H; van der Stoep N; Tucker MA; Wadt KAW; Yang XR; Newton-Bishop JA; Kanetsky PA
Article: LANCET CHILD & ADOLESCENT HEALTH. 2019;3(5):332-342
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort
Pellegrini C; Botta F; Massi D; Martorelli C; Facchetti F; Gandini S; Maisonneuve P; Avril M-F; Demenais F; Bressac-de Paillerets B; Hoiom V; Cust AE; Anton-Culver H; Gruber SB; Gallagher RP; Marrett L; Zanetti R; Dwyer T; Thomas NE; Begg CB; Berwick M; Puig S; Potrony M; Nagore E; Ghiorzo P; Menin C; Manganoni AM; Rodolfo M; Brugnara S; Passoni E; Sekulovic LK; Baldini F; Guida G; Stratigos A; Ozdemir F; Ayala F; Fernandez-de-Misa R; Quaglino P; Ribas G; Romanini A; Migliano E; Stanganelli I; Kanetsky PA; Antonietta Pizzichetta M; Garcia-Borron JC; Nan H; Landi MT; Little J; Newton-Bishop J; Sera F; Fargnoli MC; Raimondi S; Massi D; Pastorino L; Menin C; Alaibac M; Manganoni AM; Facchetti F; Rodolfo M; Ferrari A; Valeri B; Fargnoli MC; Pellegrini C; Brugnara S; Sicher M; Mangiola D; Passoni E; Nazzaro G; Baldini F; Tosti G; Gandini S; Mazzarol G; Guida G; Guida S; Giudice G; Ayala F; Quaglino P; Ribero S; Astrua C; Romanini A; Migliano E; Stanganelli I; Mazzoni L; Pizzichetta MA; Berwick M; Begg C; Orlow I; Mujumdar U; Hummer A; Busam K; Roy P; Cotignola J; Monroe Y; Armstrong B; Kricker A; Litchfield M; Tucker P; Stephens N; Gallagher R; Switzer T; Marrett L; Theis B; From L; Chowdhury N; Vanasse L; Purdue M; Northrup D; Zanetti R; Rosso S; Sacerdote C; Anton-Culver H; Leighton N; Gildea M; Gruber S; Bonner J; Jeter J; Klotz J; Wilcox H; Weiss H; Millikan R; Thomas N; Mattingly D; Player J; Tse C-K; Rebbeck T; Kanetsky P; Walker A; Panossian S; Mohrenweiser H; Setlow R; Raimondi S; Autier P; Fargnoli MC; Kanetsky PA; Landi MT; Little J; Newton-Bishop J; Sera F; Caini S; Gandini S; Maisonneuve P; Hofman A; Kayser M; Liu F; Nijsten T; Uitterlinden AG; Kumar R; Bishop T; Elliott F; Nagore E; Lazovich D; Polsky D; Hansson J; Hoiom V; Ghiorzo P; Pastorino L; Gruis NA; Bavinck JNB; Aguilera P; Badenas C; Carrera C; Gimenez-Xavier P; Tell-Marti G; Dwyer T; Blizzard L; Cochrane J; Branicki W; Debniak T; Morling N; Johansen P; Mayne S; Bale A; Cartmel B; Ferrucci L; Pfeiffer R; Palmieri G; Ribas G; Menin C; Stratigos A; Kypreou K; Bowcock A; Cornelius L; Council ML; Motokawa T; Anno S; Helsing P; Andresen PA; Guida G; Guida S; Wong TH
Article: JOURNAL OF MEDICAL GENETICS. 2018;55(10):661-668
CM-Score: a validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe
Potjer TP; Helgadottir H; Leenheer M; van der Stoep N; Gruis NA; Hoiom V; Olsson H; van Doorn R; Vasen HFA; van Asperen CJ; Dekkers OM; Hes FJ
Article: GENETICS IN MEDICINE. 2018;20(9):1087-1090
Phenocopies in melanoma-prone families with germ-line CDKN2A mutations
Helgadottir H; Olsson H; Tucker MA; Yang XR; Hoiom V; Goldstein AM
Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2017;137(12):2606-2612
Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families
Taylor NJ; Mitra N; Goldstein AM; Tucker MA; Avil M-F; Azizi E; Bergman W; Bishop DT; Bressac-de Paillerets B; Bruno W; Calista D; Cannon-Albright LA; Cuellar F; Cust AE; Demenais F; Elder DE; Gerdes A-M; Ghiorzo P; Grazziotin TC; Hansson J; Harland M; Hayward NK; Hocevar M; Hoiom V; Ingvar C; Landi MT; Landman G; Larre-Borges A; Leachman SA; Mann GJ; Nagore E; Olsson H; Palmer JM; Peric B; Pjanova D; Pritchard A; Puig S; van der Stoep N; Wadt KAW; Whitaker L; Yang XR; Bishop JAN; Gruis NA; Kanetsky PA
Article: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2017;77(5):893-901
Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status
Helgadottir H; Tuominen R; Olsson H; Hansson J; Hoiom V
Article: CELL DEATH & DISEASE. 2017;8(8):e3029
Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells
Azimi A; Tuominen R; Svedman FC; Caramuta S; Pernemalm M; Stolt MF; Kanter L; Kharaziha P; Lehtio J; Johansson CH; Holom V; Hansson J; Brage SE
Article: ANALYTICAL AND BIOANALYTICAL CHEMISTRY. 2017;409(15):3749-3756
Simple and cost-effective liquid chromatography-mass spectrometry method to measure dabrafenib quantitatively and six metabolites semi-quantitatively in human plasma
Vikingsson S; Dahlberg J-O; Hansson J; Hoiom V; Green H
Article: LAKARTIDNINGEN. 2017;114:ELAM
[Increased knowledge on familial melanoma and the underlying genetics].
Helgadottir H; Nielsen K; Höiom V
Article: HUMAN GENETICS. 2016;135(11):1241-1249
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations
Yang XR; Rotunno M; Xiao Y; Ingvar C; Helgadottir H; Pastorino L; van Doorn R; Bennett H; Graham C; Sampson JN; Malasky M; Vogt A; Zhu B; Bianchi-Scarra G; Bruno W; Queirolo P; Fornarini G; Hansson J; Tuominen R; Burdett L; Hicks B; Hutchinson A; Jones K; Yeager M; Chanock SJ; Landi MT; Hoiom V; Olsson H; Gruis N; Ghiorzo P; Tucker MA; Goldstein AM
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2016;108(11):djw135
Germline CDKN2A Mutation Status and Survival in Familial Melanoma Cases
Helgadottir H; Hoiom V; Tuominen R; Nielsen K; Jonsson G; Olsson H; Hansson J
Journal article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2016;136(9):1914-1917
Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip Project.
Tagliabue E; Gandini S; García-Borrón JC; Maisonneuve P; Newton-Bishop J; Polsky D; Lazovich D; Kumar R; Ghiorzo P; Ferrucci L; Gruis NA; Puig S; Kanetsky PA; Motokawa T; Ribas G; Landi MT; Fargnoli MC; Wong TH; Stratigos A; Helsing P; Guida G; Autier P; Han J; Little J; Sera F; Raimondi S; M-SKIP Study group
Article: BIOMEDICAL CHROMATOGRAPHY. 2016;30(8):1234-1239
Novel rapid liquid chromatography tandem masspectrometry method for vemurafenib and metabolites in human plasma, including metabolite concentrations at steady state
Vikingsson S; Stromqvist M; Svedberg A; Hansson J; Hoiom V; Green H
Article: GENES CHROMOSOMES & CANCER. 2016;55(7):601-611
The Role of Germline Alterations in the DNA Damage Response Genes BRIP1 and BRCA2 in Melanoma Susceptibility
Tuominen R; Engstrom PG; Helgadottir H; Eriksson H; Unneberg P; Kjellqvist S; Yang M; Linden D; Edsgard D; Hansson J; Hoiom V
Article: INTERNATIONAL JOURNAL OF CANCER. 2015;137(9):2220-2226
CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies
Helgadottir H; Hoiom V; Tuominen R; Jonsson G; Mansson-Brahme E; Olsson H; Hansson J
Article: NATURE GENETICS. 2015;47(9):987-995
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma
Law MH; Bishop DT; Lee JE; Brossard M; Martin NG; Moses EK; Song F; Barrett JH; Kumar R; Easton DF; Pharoah PDP; Swerdlow AJ; Kypreou KP; Taylor JC; Harland M; Randerson-Moor J; Akslen LA; Andresen PA; Avril M-F; Azizi E; Scarra GB; Brown KM; Debniak T; Duffy DL; Elder DE; Fang S; Friedman E; Galan P; Ghiorzo P; Gillanders EM; Goldstein AM; Gruis NA; Hansson J; Helsing P; Hocevar M; Hoeiom V; Ingvar C; Kanetsky PA; Chen WV; Landi MT; Lang J; Lathrop GM; Lubinski J; Mackie RM; Mann GJ; Molven A; Montgomery GW; Novakovic S; Olsson H; Puig S; Puig-Butille JA; Qureshi AA; Radford-Smith GL; van der Stoep N; van Doorn R; Whiteman DC; Craig JE; Schadendorf D; Simms LA; Burdon KP; Nyholt DR; Pooley KA; Orr N; Stratigos AJ; Cust AE; Ward SV; Hayward NK; Han J; Schulze H-J; Dunning AM; Bishop JAN; Demenais F; Amos CI; MacGregor S; Iles MM
Article: INTERNATIONAL JOURNAL OF CANCER. 2015;136(6):1351-1360
Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions
Barrett JH; Taylor JC; Bright C; Harland M; Dunning AM; Akslen LA; Andresen PA; Avril M-F; Azizi E; Scarra GB; Brossard M; Brown KM; Debniak T; Elder DE; Friedman E; Ghiorzo P; Gillanders EM; Gruis NA; Hansson J; Helsing P; Hocevar M; Hoiom V; Ingvar C; Landi MT; Lang J; Lathrop GM; Lubinski J; Mackie RM; Molven A; Novakovic S; Olsson H; Puig S; Anton Puig-Butille J; van der Stoep N; van Doorn R; van Workum W; Goldstein AM; Kanetsky PA; Pharoah PDP; Demenais F; Hayward NK; Newton Bishop JA; Bishop DT; Iles MM
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2014;106(10):dju267
The Effect on Melanoma Risk of Genes Previously Associated With Telomere Length
Iles MM; Bishop DT; Taylor JC; Hayward NK; Brossard M; Cust AE; Dunning AM; Lee JE; Moses EK; Akslen LA; Andresen PA; Avril M-F; Azizi E; Scarra GB; Brown KM; Debniak T; Elder DE; Friedman E; Ghiorzo P; Gillanders EM; Goldstein AM; Gruis NA; Hansson J; Harland M; Helsing P; Hocevar M; Hoiom V; Ingvar C; Kanetsky PA; Landi MT; Lang J; Lathrop GM; Lubinski J; Mackie RM; Martin NG; Molven A; Montgomery GW; Novakovic S; Olsson H; Puig S; Anton Puig-Butille J; Radford-Smith GL; Randerson-Moor J; van der Stoep N; van Doorn R; Whiteman DC; MacGregor S; Pooley KA; Ward SV; Mann GJ; Amos CI; Pharoah PDP; Demenais F; Law MH; Bishop JAN; Barrett JH
Article: INTERNATIONAL JOURNAL OF CANCER. 2014;135(7):1625-1633
Inherited variation in the PARP1 gene and survival from melanoma
Davies JR; Jewell R; Affleck P; Anic GM; Randerson-Moor J; Ozola A; Egan KM; Elliott F; Garcia-Casado Z; Hansson J; Harland M; Hoiom V; Jian G; Jonsson G; Kumar R; Nagore E; Wendt J; Olsson H; Park JY; Patel P; Pjanova D; Puig S; Schadendorf D; Rachakonda PS; Snowden H; Stratigos AJ; Bafaloukos D; Ogbah Z; Sucker A; Van den Oord JJ; Van Doorn R; Walker C; Okamoto I; Wolter P; Barrett JH; Bishop DT; Newton-Bishop J
Article: JOURNAL OF MEDICAL GENETICS. 2014;51(8):545-552
High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families
Helgadottir H; Hoiom V; Jonsson G; Tuominen R; Ingvar C; Borg A; Olsson H; Hansson J
Article: CANCER GENETICS. 2014;207(3):70-74
Investigation of a putative melanoma susceptibility locus at chromosome 3q29
Tuominen R; Jonsson G; Enerback C; Appelqvist F; Olsson H; Ingvar C; Hansson J; Hoiom V
Article: PIGMENT CELL & MELANOMA RESEARCH. 2014;27(2):234-243
An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study
Davies JR; Field S; Randerson-Moor J; Harland M; Kumar R; Anic GM; Nagore E; Hansson J; Hoeiom V; Joensson G; Gruis NA; Park JY; Guan J; Rachakonda PS; Wendt J; Pjanova D; Puig S; Schadendorf D; Okamoto I; Olsson H; Affleck P; Garcia-Casado Z; Anton Puig-Butille J; Stratigos AJ; Kodela E; Donina S; Sucker A; Hosen I; Egan KM; Barrett JH; van Doorn R; Bishop DT; Newton-Bishop J
Article: JOURNAL OF DERMATOLOGICAL SCIENCE. 2013;72(3):284-289
KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma
Zebary A; Omholt K; Vassilaki I; Hoiom V; Linden D; Viberg L; Kanter-Lewensohn L; Johansson CH; Hansson J
Article: NATURE GENETICS. 2013;45(4):428-432
A variant in FTO shows association with melanoma risk not due to BMI
Iles MM; Law MH; Stacey SN; Han J; Fang S; Pfeiffer R; Harland M; MacGregor S; Taylor JC; Aben KK; Akslen LA; Avril M-F; Azizi E; Bakker B; Benediktsdottir KR; Bergman W; Scarra GB; Brown KM; Calista D; Chaudru V; Fargnoli MC; Cust AE; Demenais F; Waal ACD; Debniak T; Elder DE; Friedman E; Galan P; Ghiorzo P; Gillanders EM; Goldstein AM; Gruis NA; Hansson J; Helsing P; Hocevar M; Hoiom V; Hopper JL; Ingvar C; Janssen M; Jenkins MA; Kanetsky PA; Kiemeney LA; Lang J; Lathrop GM; Leachman S; Lee JE; Lubinski J; Mackie RM; Mann GJ; Martin NG; Mayordomo JI; Molven A; Mulder S; Nagore E; Novakovic S; Okamoto I; Olafsson JH; Olsson H; Pehamberger H; Peris K; Grasa MP; Planelles D; Puig S; Puig-Butille JA; Randerson-Moor J; Requena C; Rivoltini L; Rodolfo M; Santinami M; Sigurgeirsson B; Snowden H; Song F; Sulem P; Thorisdottir K; Tuominen R; Van Belle P; van der Stoep N; van Rossum MM; Wei Q; Wendt J; Zelenika D; Zhang M; Landi MT; Thorleifsson G; Bishop DT; Amos CI; Hayward NK; Stefansson K; Bishop JAN; Barrett JH
Article: GENES CHROMOSOMES & CANCER. 2013;52(4):378-384
Hereditary uveal melanoma: A report of a germline mutation in BAP1
Hoiom V; Edsgard D; Helgadottir H; Eriksson H; All-Ericsson C; Tuominen R; Ivanova I; Lundeberg J; Emanuelsson O; Hansson J
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(15_suppl):8588
KIT , NRAS , BRAF , and PTEN alterations in acral lentiginous melanomas.
Zebary A; Omholt K; Hoiom V; Johansson C; Linden D; Vassilaki I; Hansson J
Article: PIGMENT CELL & MELANOMA RESEARCH. 2012;25(3):384-394
Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study
Davies JR; Randerson-Moor J; Kukalizch K; Harland M; Kumar R; Madhusudan S; Nagore E; Hansson J; Hoiom V; Ghiorzo P; Gruis NA; Kanetsky PA; Wendt J; Pjanova D; Puig S; Saiag P; Schadendorf D; Soufir N; Okamoto I; Affleck P; Garcia-Casado Z; Ogbah Z; Ozola A; Queirolo P; Sucker A; Barrett JH; van Doorn R; Bishop DT; Newton-Bishop J
Article: GENES CHROMOSOMES & CANCER. 2011;50(12):1076-1084
Genome-wide Linkage Analysis of Swedish Families to Identify Putative Susceptibility Loci for Cutaneous Malignant Melanoma
Hoiom V; Tuominen R; Hansson J
Article: NATURE GENETICS. 2011;43(11):1108-1U98
Genome-wide association study identifies three new melanoma susceptibility loci
Barrett JH; Iles MM; Harland M; Taylor JC; Aitken JF; Andresen PA; Akslen LA; Armstrong BK; Avril M-F; Azizi E; Bakker B; Bergman W; Bianchi-Scarra G; Bressac-de Paillerets B; Calista D; Cannon-Albright LA; Corda E; Cust AE; Debniak T; Duffy D; Dunning AM; Easton DF; Friedman E; Galan P; Ghiorzo P; Giles GG; Hansson J; Hocevar M; Hoeiom V; Hopper JL; Ingvar C; Janssen B; Jenkins MA; Joensson G; Kefford RF; Landi G; Landi MT; Lang J; Lubinski J; Mackie R; Malvehy J; Martin NG; Molven A; Montgomery GW; van Nieuwpoort FA; Novakovic S; Olsson H; Pastorino L; Puig S; Puig-Butille JA; Randerson-Moor J; Snowden H; Tuominen R; VanBelle P; van der Stoep N; Whiteman DC; Zelenika D; Han J; Fang S; Lee JE; Wei Q; Lathrop GM; Gillanders EM; Brown KM; Goldstein AM; Kanetsky PA; Mann GJ; MacGregor S; Elder DE; Amos CI; Hayward NK; Gruis NA; Demenais F; Bishop JAN; Bishop DT
Article: PLOS ONE. 2011;6(12):e29451
Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression.
Schoof N; Iles MM; Bishop DT; Newton-Bishop JA; Barrett JH; Genomel Consortium
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2010;102(20):1568-1583
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study
Demenais F; Mohamdi H; Chaudru V; Goldstein AM; Bishop JAN; Bishop DT; Kanetsky PA; Hayward NK; Gillanders E; Elder DE; Avril MF; Azizi E; van Belle P; Bergman W; Bianchi-Scarra G; Bressac-de Paillerets B; Calista D; Carrera C; Hansson J; Harland M; Hogg D; Hoiom V; Holland EA; Ingvar C; Landi MT; Lang JM; Mackie RM; Mann GJ; Ming ME; Njauw CJ; Olsson H; Palmer J; Pastorino L; Puig S; Randerson-Moor J; Stark M; Tsao H; Tucker MA; van der Velden P; Yang XR; Gruis N
Article: AMERICAN JOURNAL OF HUMAN GENETICS. 2010;87(1):6-16
IRF4 Variants Have Age-Specific Effects on Nevus Count and Predispose to Melanoma
Duffy DL; Iles MM; Glass D; Zhu G; Barrett JH; Hoiom V; Zhao ZZ; Sturm RA; Soranzo N; Hammond C; Kvaskoff M; Whiteman DC; Mangino M; Hansson J; Newton-Bishop JA; Bataille V; Hayward NK; Martin NG; Bishop DT; Spector TD; Montgomery GW
Article: NATURE GENETICS. 2009;41(8):920-U85
Genome-wide association study identifies three loci associated with melanoma risk
Bishop DT; Demenais F; Iles MM; Harland M; Taylor JC; Corda E; Randerson-Moor J; Aitken JF; Avril M-F; Azizi E; Bakker B; Bianchi-Scarra G; Bressac-de Paillerets B; Calista D; Cannon-Albright LA; Chin-A-Woeng T; Debniak T; Galore-Haskel G; Ghiorzo P; Gut I; Hansson J; Hocevar M; Hoiom V; Hopper JL; Ingvar C; Kanetsky PA; Kefford RF; Landi MT; Lang J; Lubinski J; Mackie R; Malvehy J; Mann GJ; Martin NG; Montgomery GW; van Nieuwpoort FA; Novakovic S; Olsson H; Puig S; Weiss M; van Workum W; Zelenika D; Brown KM; Goldstein AM; Gillanders EM; Boland A; Galan P; Elder DE; Gruis NA; Hayward NK; Lathrop GM; Barrett JH; Bishop JAN
Article: NATURE GENETICS. 2009;41(8):909-914
New common variants affecting susceptibility to basal cell carcinoma
Stacey SN; Sulem P; Masson G; Gudjonsson SA; Thorleifsson G; Jakobsdottir M; Sigurdsson A; Gudbjartsson DF; Sigurgeirsson B; Benediktsdottir KR; Thorisdottir K; Ragnarsson R; Scherer D; Hemminki K; Rudnai P; Gurzau E; Koppova K; Botella-Estrada R; Soriano V; Juberias P; Saez B; Gilaberte Y; Fuentelsaz V; Corredera C; Grasa M; Hoiom V; Lindblom A; Bonenkamp JJ; van Rossum MM; Aben KKH; de Vries E; Santinami M; Di Mauro MG; Maurichi A; Wendt J; Hochleitner P; Pehamberger H; Gudmundsson J; Magnusdottir DN; Gretarsdottir S; Holm H; Steinthorsdottir V; Frigge ML; Blondal T; Saemundsdottir J; Bjarnason H; Kristjansson K; Bjornsdottir G; Okamoto I; Rivoltini L; Rodolfo M; Kiemeney LA; Hansson J; Nagore E; Mayordomo JI; Kumar R; Karagas MR; Nelson HH; Gulcher JR; Rafnar T; Thorsteinsdottir U; Olafsson JH; Kong A; Stefansson K
Article: PIGMENT CELL & MELANOMA RESEARCH. 2009;22(2):196-204
MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters
Hoiom V; Tuominen R; Kaller M; Linden D; Ahmadian A; Mansson-Brahme E; Egyhazi S; Sjoberg K; Lundeberg J; Hansson J
Article: NATURE GENETICS. 2009;41(2):221-227
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types
Rafnar T; Sulem P; Stacey SN; Geller F; Gudmundsson J; Sigurdsson A; Jakobsdottir M; Helgadottir H; Thorlacius S; Aben KKH; Bloendal T; Thorgeirsson TE; Thorleifsson G; Kristjansson K; Thorisdottir K; Ragnarsson R; Sigurgeirsson B; Skuladottir H; Gudbjartsson T; Isaksson HJ; Einarsson GV; Benediktsdottir KR; Agnarsson BA; Olafsson K; Salvarsdottir A; Bjarnason H; Asgeirsdottir M; Kristinsson KT; Matthiasdottir S; Sveinsdottir SG; Polidoro S; Hoeiom V; Botella-Estrada R; Hemminki K; Rudnai P; Bishop DT; Campagna M; Kellen E; Zeegers MP; de Verdier P; Ferrer A; Isla D; Vidal MJ; Andres R; Saez B; Juberias P; Banzo J; Navarrete S; Tres A; Kan D; Lindblom A; Gurzau E; Koppova K; de Vegt F; Schalken JA; van der Heijden HFM; Smit HJ; Termeer RA; Oosterwijk E; van Hooij O; Nagore E; Porru S; Steineck G; Hansson J; Buntinx F; Catalona WJ; Matullo G; Vineis P; Kiltie AE; Mayordomo JI; Kumar R; Kiemeney LA; Frigge ML; Jonsson T; Saemundsson H; Barkardottir RB; Jonsson E; Jonsson S; Olafsson JH; Gulcher JR; Masson G; Gudbjartsson DF; Kong A; Thorsteinsdottir U; Stefansson K
Article: NATURE GENETICS. 2008;40(11):1313-1318
Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits
Stacey SN; Gudbjartsson DF; Sulem P; Bergthorsson JT; Kumar R; Thorleifsson G; Sigurdsson A; Jakobsdottir M; Sigurgeirsson B; Benediktsdottir KR; Thorisdottir K; Ragnarsson R; Scherer D; Rudnai P; Gurzau E; Koppova K; Hoiom V; Botella-Estrada R; Soriano V; Juberias P; Grasa M; Carapeto FJ; Tabuenca P; Gilaberte Y; Gudmundsson J; Thorlacius S; Helgason A; Thorlacius T; Jonasdottir A; Blondal T; Gudjonsson SA; Jonsson GF; Saemundsdottir J; Kristjansson K; Bjornsdottir G; Sveinsdottir SG; Mouy M; Geller F; Nagore E; Mayordomo JI; Hansson J; Rafnar T; Kong A; Olafsson JH; Thorsteinsdottir U; Stefansson K
Article: NATURE GENETICS. 2008;40(7):886-891
ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma
Gudbjartsson DF; Sulem P; Stacey SN; Goldstein AM; Rafnar T; Sigurgeirsson B; Benediktsdottir KR; Thorisdottir K; Ragnarsson R; Sveinsdottir SG; Magnusson V; Lindblom A; Kostulas K; Botella-Estrada R; Soriano V; Juberias P; Grasa M; Saez B; Andres R; Scherer D; Rudnai P; Gurzau E; Koppova K; Kiemeney LA; Jakobsdottir M; Steinberg S; Helgason A; Gretarsdottir S; Tucker MA; Mayordomo JI; Nagore E; Kumar R; Hansson J; Olafsson JH; Gulcher J; Kong A; Thorsteinsdottir U; Stefansson K
Article: JOURNAL OF MEDICAL GENETICS. 2007;44(2):99-106
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents
Goldstein AM; Chan M; Harland M; Hayward NK; Demenais F; Bishop DT; Azizi E; Bergman W; Bianchi-Scarra G; Bruno W; Calista D; Albright LAC; Chaudru V; Chompret A; Cuellar F; Elder DE; Ghiorzo P; Gillanders EM; Gruis NA; Hansson J; Hogg D; Holland EA; Kanetsky PA; Kefford RF; Landi MT; Lang J; Leachman SA; MacKie RM; Magnusson V; Mann GJ; Bishop JN; Palmer JM; Puig S; Puig-Butille JA; Stark M; Tsao H; Tucker MA; Whitaker L; Yakobson E
Article: CANCER RESEARCH. 2006;66(20):9818-9828
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL
Goldstein AM; Chan M; Harland M; Gillanders EM; Hayward NK; Avril M-F; Azizi E; Bianchi-Scarra G; Bishop DT; Bressac-de Paillerets B; Bruno W; Calista D; Cannon Albright LA; Demenais F; Elder DE; Ghiorzo P; Gruis NA; Hansson J; Hogg D; Holland EA; Kanetsky PA; Kefford RF; Landi MT; Lang J; Leachman SA; MacKie RM; Magnusson V; Mann GJ; Niendorf K; Newton Bishop J; Palmer JM; Puig S; Puig-Butille JA; de Snoo FA; Stark M; Tsao H; Tucker MA; Whitaker L; Yakobson E
Article: CLINICAL CHEMISTRY. 2005;51(12):2388-2391
Detection of MC1R polymorphisms with protease-mediated allele-specific extension as an alternative to direct sequencing
Käller M; Tuominen R; Ahmadian A; Magnusson V; Egyhazi S; Hansson J; Lundeberg J
Article: GENES AND IMMUNITY. 2004;5(2):130-137
Both risk alleles for FcγRIIA and FcγRIIIA are susceptibility factors for SLE:: a unifying hypothesis
Magnusson V; Johanneson B; Lima G; Odeberg J; Alarcón-Segivuam D; Alarcón-Riquelme ME
Article: NATURE GENETICS. 2002;32(4):666-669
A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans
Prokunina L; Castillejo-López C; Öberg F; Gunnarsson I; Berg L; Magnusson V; Brookes AJ; Tentler D; Kristjansdóttir H; Gröndal G; Bolstad AI; Svenungsson E; Lundberg I; Sturfelt G; Jönssen A; Truedsson L; Lima G; Alcocer-Varela J; Jonsson R; Gyllensten UB; Harley JB; Alarcón-Segovia D; Steinsson K; Alarcón-Riquelme ME
Article: GENOMICS. 2000;70(3):307-314
Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus
Magnusson V; Lindqvist AKB; Castillejo-López C; Kristjánsdottir H; Steinsson K; Gröndal G; Sturfelt G; Truedsson L; Svenungsson E; Lundberg I; Gunnarsson I; Bolstad AI; Haga HJ; Jonsson R; Klareskog L; Alcocer-Varela J; Alarcón-Segovia D; Terwilliger JD; Gyllensten UB; Alarcón-Riquelme ME
Article: JOURNAL OF AUTOIMMUNITY. 2000;14(2):169-178
A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q
Lindqvist AKB; Steinsson K; Johanneson B; Kristjánsdóttir H; Arnasson A; Gröndal G; Jonasson I; Magnusson V; Sturfelt G; Truedsson L; Svenungsson E; Lundberg I; Terwilliger JD; Gyllensten UB; Alarcón-Riquelme ME
Show more

All other publications

Letter: ACTA ONCOLOGICA. 2023;62(12):1967-1972
Familial features affecting the melanoma risk in CDKN2A-negative melanoma families: a study based on the Swedish Cancer Registry
Helgadottir H; Schultz K; Lapins J; Holom V
Letter: ACTA ONCOLOGICA. 2023;62(6):565-570
BAP1 genetic testing among melanoma and cancer-prone families in Sweden
Helgadottir H; Schultz K; Lapins J; Vassilaki I; All-Eriksson C; Hoiom V
Meeting abstract: JOURNAL OF CLINICAL ONCOLOGY. 2021;39(15):9556
Plasma thymidine kinase activity (TKa) as a novel prognostic biomarker in metastatic melanoma.
Helgadottir H; Svedman FC; Jalsenius M; Hoiom V; Rotstein S; Brage SE; Grozman V; Soderdahl F; Ny L; Bergqvist M
Meeting abstract: ANNALS OF ONCOLOGY. 2020;31:S766
Multiple primary melanoma incidence trends over five decades, a nationwide population-based study
Helgadottir H; Isaksson K; Fritz I; Ingvar C; Lapins J; Hoiom V; Newton-Bishop J; Olsson H
Meeting abstract: ANNALS OF ONCOLOGY. 2020;31:S759
BRAF and MEK inhibition in CDKN2A germline carriers and BRAF mutant melanoma
Spagnolo F; Dalmasso B; Helgadottir H; Hoiom V; van Doorn R; Kapiteijn E; Potrony M; Puig S; Queirolo P; Ghiorzo P
Conference publication: ANNALS OF ONCOLOGY. 2019;30:xi8-xi9
27P Single-nucleotide polymorphism variation (SNV): Possible candidates as predictive biomarkers to response and progression free survival (PFS) in cutaneous malignant melanoma (CMM) patients treated with immune checkpoint inhibitors (ICI)
Svedman FC; Yang M; Tuominen R; Brage SE; Höiom V
Meeting abstract: ANNALS OF ONCOLOGY. 2019;30:vii8
Therapeutic implications of MTH1 inhibitor TH1579 in cutaneous malignant melanoma
Das I; Gad H; Brautigam L; Pudelko L; Tuominen R; Hoiom V; Almlof I; Hansson J; Helleday T; Brage SE; Berglund UW
Conference publication: ANNALS OF ONCOLOGY. 2019;30:v559
1369P Genes involved in DNA replication, chromatin remodeling and cell cycle as potential biomarkers for therapy outcome to immune therapy in patients with metastatic cutaneous malignant melanoma
Svedman FC; Das I; Tuominen R; Ramqvist ED; Hansson J; Höiom V; Brage SE
Corrigendum: NATURE COMMUNICATIONS. 2019;10(1):299
Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways (vol 9, 4774, 2018)
Duffy DL; Zhu G; Li X; Sanna M; Iles MM; Jacobs LC; Evans DM; Yazar S; Beesley J; Law MH; Kraft P; Visconti A; Taylor JC; Liu F; Wright MJ; Henders AK; Bowdler L; Glass D; Ikram MA; Uitterlinden AG; Madden PA; Heath AC; Nelson EC; Green AC; Chanock S; Barrett JH; Brown MA; Hayward NK; MacGregor S; Sturm RA; Hewitt AW; Kayser M; Hunter DJ; Bishop JAN; Spector TD; Montgomery GW; Mackey DA; Smith GD; Nijsten TE; Bishop DT; Bataille V; Falchi M; Han J; Martin NG; Lee JE; Brossard M; Moses EK; Song F; Kumar R; Easton DF; Pharoah PDP; Swerdlow AJ; Kypreou KP; Harland M; Randerson-Moor J; Akslen LA; Andresen PA; Avril M-F; Azizi E; Scarra GB; Brown KM; Debniak T; Elder DE; Fang S; Friedman E; Galan P; Ghiorzo P; Gillanders EM; Goldstein AM; Gruis NA; Hansson J; Helsing P; Hocevar M; Hoiom V; Ingvar C; Kanetsky PA; Chen WV; Landi MT; Lang J; Lathrop GM; Lubinski J; Mackie RM; Mann GJ; Molven A; Novakovic S; Olsson H; Puig S; Puig-Butille JA; Radford-Smith GL; van der Stoep N; van Doorn R; Whiteman DC; Craig JE; Schadendorf D; Simms LA; Burdon KP; Nyholt DR; Pooley KA; Orr N; Stratigos AJ; Cust AE; Ward SV; Schulze H-J; Dunning AM; Demenais F; Amos CI
Review: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2018;110(12):1328-1341
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide
Walpole S; Pritchard AL; Cebulla CM; Pilarski R; Stautberg M; Davidorf FH; de la Fouchardiere A; Cabaret O; Golmard L; Stoppa-Lyonnet D; Garfield E; Njauw C-N; Cheung M; Turunen JA; Repo P; Jarvinen R-S; van Doorn R; Jager MJ; Luyten GPM; Marinkovic M; Chau C; Potrony M; Hoiom V; Helgadottir H; Pastorino L; Bruno W; Andreotti V; Dalmasso B; Ciccarese G; Queirolo P; Mastracci L; Wadt K; Kiilgaard JF; Speicher MR; van Poppelen N; Kilic E; Al-Jamal RT; Dianzani I; Betti M; Bergmann C; Santagata S; Dahiya S; Taibjee S; Burke J; Poplawski N; O'Shea SJ; Newton-Bishop J; Adlard J; Adams DJ; Lane A-M; Kim I; Klebe S; Racher H; Harbour JW; Nickerson ML; Murali R; Palmer JM; Howlie M; Symmons J; Hamilton H; Warrier S; Glasson W; Johansson P; Robles-Espinoza CD; Ossio R; de Klein A; Puig S; Ghiorzo P; Nielsen M; Kivela TT; Tsao H; Testa JR; Gerami P; Stern M-H; Bressac-de Paillerets B; Abdel-Rahman MH; Hayward NK
Letter: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2016;136(5):1066-1069
Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families
Taylor NJ; Handorf EA; Mitra N; Avril M-F; Azizi E; Bergman W; Bianchi-Scarra G; Bishop DT; Bressac-de Paillerets B; Calista D; Cannon-Albright LA; Cuellar F; Cust AE; Demenais F; Elder DE; Friedman E; Gerdes A-M; Ghiorzo P; Goldstein AM; Grazziotin TC; Hansson J; Hayward NK; Hocevar M; Hoiom V; Holland EA; Ingvar C; Landi MT; Landman G; Larre-Borges A; Leachman SA; Mann GJ; Nagore E; Olsson H; Palmer J; Peric B; Pjanova D; Puig S; Schmid H; van der Stoep N; Tucker MA; Wadt KAW; Whitaker L; Yang XR; Bishop JAN; Gruis NA; Kanetsky PA
Review: APPLICATION OF CLINICAL GENETICS. 2016;9:147-155
The genetics of uveal melanoma: current insights.
Helgadottir H; Höiom V
Letter: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2014;134(1):287-290
Somatic BRAF and NRAS Mutations in Familial Melanomas with Known Germline CDKN2A Status: A GenoMEL Study
Zebary A; Omholt K; van Doorn R; Ghiorzo P; Harbst K; Johansson CH; Hoiom V; Jonsson G; Pjanova D; Puig S; Scarra GB; Harland M; Olsson H; Brage SE; Palmer J; Kanter-Lewensohn L; Vassilaki I; Hayward NK; Newton-Bishop J; Gruis NA; Hansson J
Editorial comment: ARTHRITIS & RHEUMATOLOGY. 2004;50(4):1348-1350
Polymorphisms of the Fcγ receptor type IIB gene are not associated with systemic lupus erythematosus in the Swedish population
Magnusson V; Zunec R; Odeberg J; Sturfelt G; Truedsson L; Alarcón-Riquelme ME
Review: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2001;54(1-2):55-61
Cytokine polymorphisms in systemic lupus erythematosus and Sjogren's syndrome
Magnusson V; Nakken B; Bolstad AI; Alarcón-Riquelme ME

Grants

Massive parallel sequencing and genotyping strategies for prediction of chemotherapy induced adverse drug reactions
Swedish Research Council
1 January 2012 - 31 December 2016

Articles

All other publications

Grants

News from KI

Events from KI